Genetic discrimination in health insurance: Current legal protections and industry practices

被引：10

作者：

Pollitz, Karen

Peshkin, Beth N.

Bangit, Eliza

Lucia, Kevin

机构：

[1] Georgetown Univ, Hlth Policy Inst, Washington, DC 20057 USA

[2] Georgetown Univ, Lombardi Comprehens Canc Ctr, Washington, DC 20057 USA

来源：

INQUIRY-THE JOURNAL OF HEALTH CARE ORGANIZATION PROVISION AND FINANCING | 2007年 / 44卷 / 03期

关键词：

D O I：

10.5034/inquiryjrnl_44.3.350

中图分类号：

R19 [保健组织与事业（卫生事业管理）];

学科分类号：

摘要：

Most states have enacted genetic nondiscrimination laws in health insurance, and federal legislation is pending in Congress. Scientists worry fear of discrimination discourages some patients from participating in clinical trials and hampers important medical research. This paper describes a study of medical underwriting practices in the individual health insurance market related to genetic information. Underwriters from 23 companies participated in a survey that asked them to underwrite four pairs of hypothetical applicants health insurance. One person in each pair had received a positive genetic test result indicating increased risk for future health condition breast cancer, hemochromatosis, or heart disease-for a total of 92 underwriting decisions on applications involving genetic information. In seven of these 92 applications, underwriters said they would deny coverage, place a surcharge on premiums, or limit covered benefits based on an applicant's genetic information.

引用

页码：350 / 368

页数：19

共 34 条

[11] Laws restricting health insurers' use of genetic information: Impact on genetic discrimination [J].

Hall, MA ;

Rich, SS .

AMERICAN JOURNAL OF HUMAN GENETICS, 2000, 66 (01) :293-307

[12]

*HIAA, 1998, TEST HIAA GEN TEST

[13] Cancer statistics, 2006 [J].

Jemal, A ;

Siegel, R ;

Ward, E ;

Murray, T ;

Xu, JQ ;

Smigal, C ;

Thun, MJ .

CA-A CANCER JOURNAL FOR CLINICIANS, 2006, 56 (02) :106-130

[14] Risk-reducing salpingo-oophorectomy in women with a BRCA1 or BRCA2 mutation. [J].

Kauff, ND ;

Satagopan, JM ;

Robson, ME ;

Scheuer, L ;

Hensley, M ;

Hudis, CA ;

Ellis, NA ;

Boyd, J ;

Borgen, PI ;

Barakat, RR ;

Norton, L ;

Offit, K .

NEW ENGLAND JOURNAL OF MEDICINE, 2002, 346 (21) :1609-1615

[15]

KOWDLEY K, 2006, HFE ASS HEREDITARY H

[16] Contralateral breast cancer in BRCA1 and BRCA2 mutation carriers [J].

Metcalfe, K ;

Lynch, HT ;

Chadirian, P ;

Tung, N ;

Olivotto, V ;

Warner, E ;

Olopade, OI ;

Eisen, A ;

Weber, B ;

McLennan, J ;

Sun, P ;

Foulkes, WD ;

Narod, SA .

JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (12) :2328-2335

[17] The risk of ovarian cancer after breast cancer in BRCA1 and BRCA2 carriers [J].

Metcalfe, KA ;

Lynch, HT ;

Ghadirian, P ;

Tung, N ;

Olivotto, IA ;

Foulkes, WD ;

Warner, E ;

Olopade, O ;

Eisen, A ;

Weber, B ;

McLennan, J ;

Sun, P ;

Narod, SA .

GYNECOLOGIC ONCOLOGY, 2005, 96 (01) :222-226

[18] Ovarian cancer and high-risk women - implications for prevention, screening, and early detection [J].

Modugno, F .

GYNECOLOGIC ONCOLOGY, 2003, 91 (01) :15-31

[19]

*MYR GEN LAB INC, 2006, BRCA RISK CALC MUT P

[20]

*NAT ASS INS COMM, 2005, ACC HLTH INS IND 200

← 1 2 3 4 →